Initiating anti‑cancer treatment close to the end of life can be a complex, emotive, and sometimes controversial decision. These decisions are often multilayered, requiring careful consideration of a person’s goals of care, the clinical evidence supporting potential benefit, and the management of distressing symptoms such as pain, bleeding, or fungating tumours.
Join us as we explore the clinical reasoning, ethical considerations, and communication strategies involved in treatment decision‑making at the end of life. This session will also discuss how clinicians can best support patients and families when navigating these challenging moments.
Bronze Sponsor
